mPrepared By: Sahil Shah

B.K.School Of Business Management,

Ahmedabad.

MM

M 
  M
 À


m ision and Mission
m History
m Partitions of the company
m Current scenario
m Segments of the company
m R&D
m Manufacturing plants
m Production capacity
m Thoughts of founder
m Contact details
m Reference

MM

M 
 

 m Vision

m¦Company¶s vision is to be a leading pharmaceutical company in India

and to become a significant global player by providing high quality,
affordable and innovative solutions in medicine and treatment."

MM

M 
  
 m ission

mTo discover, develop and successfully market pharmaceutical products

to prevent, diagnose, alleviate and cure diseases.

mTo provide total customer satisfaction and achieve leadership in chosen

markets, products and services across the globe, through excellence in
technology, based on world-class research and development.

MM

M 
 
 m3istory
mCadila Laboratories was founded by Shri. Ramanbhai Patel and
Shri. Indravadanbhai Modi in 1952.

mThe company evolved over the next four decades into one of India's
established pharmaceutical companies.

mSoon it became one of the largest pharmaceutical companies of India.

MM

M 
  
 m 6 rtitions of comp ny
mIn 1995,
Cadila Laboratories

Zydus Cadila Cadila Pharmaceuticals

MM

M 
  
 m 6 rtitions of comp ny

mZydus Cadila is now being run by Mr.Pankaj Patel, son of

Mr.Ramanbhai Patel.

mCadila Pharmaceuticals is now being run by Dr.Rajiv Modi, son of

Mr.Indravadanbhai Modi.

MM

M 
  
 mÀ



mCadila Pharmaceuticals Ltd. is one of the largest privately held

pharmaceutical companies in India, headquartered at Ahmedabad, in the
state of Gujarat.
mOver the last five decades, it has been developing and manufacturing
pharmaceutical products and selling and distributing these in over 50
countries around the world.
mCadila Pharmaceuticals is the first Indian company to get IND approval
by USFDA for clinical trials to be conducted in India.
mIts last year¶s turn over was more than Rs.500 crore.

MM

M 
  
 mxifferent segments of the comp ny

R Cadiovascular
R GIT (Gastro Intestinal)
R Analgesics
R Haematinics
R Anti-infectives
R Anti-biotics
R Respiratory agents
R Anti-diabetics
R Immunologicals

MM

M 
  
 mJ&x
mOne of India's most reputed, Research based, tech-savvy pharmaceutical
companies focusing on areas - Formulations both Human and eterinary,
Active Pharmaceutical Ingredients, New Drug Discovery, Novel Drug
Delivery, Analytical Research, Phytochemistry, Biotechnology, Plant
Tissue Culture, Biosynthesis, Genetic Engineering, accines,
Immunoglobulins - the entire gamut of a True Life Sciences Company.

m¦RISORINE´-an anti T.B. drug was very much important molecule

invented by the company.

MM

M 
  M
 mJ&x
m R & D centre is Spreaded over more than 1,05,000 sq. ft. area with
latest R & D facilities, recognized by the Department of Science &
Technology, Government of India, are manned by a 150-strong scientists¶
pool.

mA centralized Quality Control & Analytical Research Laboratory has

been set up to meet the domestic and international quality standards.

mOne of the few companies in the country carrying out collaborative

research, Cadila Pharmaceuticals taps the best scientific talent in the
country and has collaborations with more than 30 leading Research and
Development centers in India.

MM

M 
  MM
 m Aorld¶s First By À dil 6h rm ceutic ls

m Aorld's first Sparfloxacin Eye Drops (Scat Eye Drops)

m Aorld's first parenteral formulation of Rabeprazole (Rabeloc)
m Aorld's first Probiotic combined with anti-infective agent
m Aorld's first manufacturer of a unique immunomodulator
m Aorld's first whole blood, rapid HI detection kit (NEA HI)

MM

M 
  M

 men force
mCadila Pharmaceuticals has a multicultural, multilingual and
multinational workforce of more than four thousand employees including
over two hundred people outside India in forty-nine countries of Africa,
CIS, Japan and USA.

mFuture plans of this company is to expand this company to each and

every corner of the world.

MM

M 
  M
  nuf cturing pl nts: Kadi,
Dholka,
Daskroi,
Buddy (Haryana),
Jammu.

MM

M 
  M

 m[lob l c le 6roduction À p cities
R Tablets: 4,320 million
R Dry Syrup:12 million bottles
R Dry powder vials:24 million
R Liquid (oral):6,000 Kilo litres
R Granules:15.6 million sachets
MM

M 
R Capsules:750 million
R ials: 90 million
R Ampoules:84 million
R Eye drops: 5 million bottles
R Ear drops: 4.6 million bottles
  M
Àlosing houghts(According to hri. odi)
Indian Pharmaceutical Industry has the potential to«

1. Bring Affordability and Accessibility of Drugs to the Masses

2. Increase Global Pharma Industry¶s Innovation Capacity to Meet Unmet Needs
3. But needs to get the basics right

³Ae try never to forget th t medicine is for the people. It is not for the profits. he
profits follow, nd if we h ve remembered th t, they h ve never f iled to ppe r.
he better we h ve remembered th t, the l rger they h ve been.´
-- hri. Indr v d nbh i odi.

11/23/2010 By:Sahil Shah 16

 m Àont ct det ils
3J Àont ct- Renu Ratra,
HR Manager,
Cadila Pharmaceuticals.
e-mail: renu@cadilapharma.co.in

Àorpor te & Jegistered ffice

ÀAxILA À J6 JA ÀA6

Sarkhej-Dholka Road,
Bhat, Ahmedabad-382 210, INDIA.
Phone : +91-2718-225001 (15 Lines)
Fax :+91-2718-225039
e-mail : website@cadilapharma.co.in

MM

M 
  M
 mJeferences:

mwww.wikipedia.com
mwww.google.com
mwww.cadilapharma.com

MM

M 
  M